Washington University School of Medicine is the medical school of Washington University in St. Louis in St. Louis, Missouri. Founded in 1891, the School of Medicine has 1,260 students, 604 of which are pursuing a medical degree with or without a combined Doctor of Philosophy or other advanced degree.

During the past decade, Washington University School of Medicine in St. Louis - Center for Clinical Studies conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 5 clinical trials were completed, i.e. on average, 125% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Washington University School of Medicine in St. Louis - Center for Clinical Studies" #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 5 trials, followed by "Mesoblast, Inc." with 3 trials sponsored, "Washington University School of Medicine" with 3 trials sponsored, "Pfizer" with 2 trials sponsored and "Novartis" with 2 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Washington University School of Medicine in St. Louis - Center for Clinical Studies" #1 collaborator was "Centers for Medicare and Medicaid Services" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Washington University School of Medicine in St. Louis - Center for Clinical Studies" are "Crohn's Disease" (3 trials), "Cytomegalovirus Infection" (2 trials), "Clostridium Difficile Infection" (1 trials), "Congenital Cytomegalovirus Infection" (1 trials) and "Contraception" (1 trials). Many other conditions were trialed in "Washington University School of Medicine in St. Louis - Center for Clinical Studies" in a lesser frequency.

Most popular intervention types in "Washington University School of Medicine in St. Louis - Center for Clinical Studies" are "Drug" (12 trials), "Other" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Valganciclovir" (3 trials), "2% lidocaine gel" (1 trials), "Clostridium difficile vaccine" (1 trials) and "MEK162, MEK inhibitor; oral" (1 trials). Other intervention names were less common.

The vast majority of trials in "Washington University School of Medicine in St. Louis - Center for Clinical Studies" are 11 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Washington University School of Medicine in St. Louis - Center for Clinical Studies". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Washington University School of Medicine in St. Louis - Center for Clinical Studies, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Washington University School of Medicine in St. Louis - Center for Clinical Studies, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".